• Raising up to $50 million through placement and share purchase plan
• Funds to be used for product development, commercialization, and global expansion
• Attaching options to be issued to investors

4DMEDICAL Ltd (ASX:4DX) has announced a capital raise of up to $50 million, comprising a placement to eligible sophisticated and professional investors and a share purchase plan for eligible shareholders. The funds raised will be used to support the company's product development, commercialization efforts, and global expansion plans for its advanced medical imaging technology. As part of the capital raise, the company will also be issuing attaching options to investors. The presentation provides detailed information on the company's business, financial performance, and growth strategy, as well as the key terms and conditions of the capital raise. The company emphasizes its commitment to delivering innovative solutions that can transform the way respiratory diseases are diagnosed and managed, and the capital raise is expected to further strengthen its position in the global medical imaging market.

The company has not provided any specific financial guidance as part of this announcement.

4DMEDICAL Ltd is focused on accelerating the commercialization of its advanced medical imaging technology, expanding its global footprint, and driving further innovation to address unmet needs in the respiratory healthcare sector. The capital raise is expected to support the company's growth strategy and position it for continued success in the future.